http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020508294-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-18 |
filingDate | 2018-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2020508294-A |
titleOfInvention | Manufacturing method of efavirenz |
abstract | The present invention relates to optically pure (S) -6-chloro- (cyclopropylethynyl) -1,4-dihydro-4- (trifluoromethyl) -2H-3,1-benzoxazin-2-one. It relates to a manufacturing method. In particular, the present invention relates to the preparation of (S) -6-chloro- (cyclopropylethynyl) -1,4-dihydro-4- (trifluoromethyl) -2H-3,1-benzoxazin-2-one. The flow synthesis method. |
priorityDate | 2017-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.